Endocrinology, Vol 103, 554-558, Copyright © 1978 by Endocrine Society

ARTICLES

Prolactin release by vasoactive intestinal polypeptide in rats

Y Kato, Y Iwasaki, J Iwasaki, H Abe, N Yanaihara and H Imura

Synthetic vasoactive intestinal polypeptide (VIP) administered either intraventricularly or iv caused a significant and dose-related increase in plasma PRL levels in urethane-anesthetized rats. The administration of naloxone, an opiate receptor antagonist, significantly blunted the plasma PRL response to VIP. Increases in plasma PRL induced by VIP were also significantly suppressed by L-dopa, a precursor of dopamine, whereas pilocarpine, a cholinergic agonist, diphenhydramine, a histamine antagonist, and cyproheptadine, an antiserotoninergic agent, did not affect the plasma PRL response to VIP. In in vitro experiments, VIP alone did not stimulate PRL release from cultured pituitary cells, but it significantly attenuated the inhibitory action of dopamine, which was not blocked by naloxone. These results suggest that VIP stimulates rat PRL secretion, at least in part, through activation of an opiate receptor in the central nervous system and by blocking the inhibitory action of a dopaminergic mechanism at the pituitary level.

This article has been cited by other articles:

				D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines Endocrinology, June 1, 2007; 148(6): 2973 - 2983. [Abstract] [Full Text] [PDF]

				M. Chesterfield, J. Janik, E. Murphree, C. Lynn, E. Schmidt, and P. Callahan Orphanin FQ/Nociceptin Is a Physiological Regulator of Prolactin Secretion in Female Rats Endocrinology, November 1, 2006; 147(11): 5087 - 5093. [Abstract] [Full Text] [PDF]

				Y. Chaiseha, O. M. Youngren, and M. E. El Halawani Expression of Vasoactive Intestinal Peptide Receptor Messenger RNA in the Hypothalamus and Pituitary Throughout the Turkey Reproductive Cycle Biol Reprod, March 1, 2004; 70(3): 593 - 599. [Abstract] [Full Text] [PDF]

				D. Romano, K. Magalon, A. Ciampini, C. Talet, A. Enjalbert, and C. Gerard Differential Involvement of the Ras and Rap1 Small GTPases in Vasoactive Intestinal and Pituitary Adenylyl Cyclase Activating Polypeptides Control of the Prolactin Gene J. Biol. Chem., December 19, 2003; 278(51): 51386 - 51394. [Abstract] [Full Text] [PDF]

				N. M. Sherwood, S. L. Krueckl, and J. E. McRory The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily Endocr. Rev., December 1, 2000; 21(6): 619 - 670. [Abstract] [Full Text]

				B. BARANOWSKA, M. RADZIKOWSKA, E. WASILEWSKA-DZIUBINSKA, K. ROGUSKI, and M. BOROWIEC The Role of VIP and Somatostatin in the Control of GH and Prolactin Release in Anorexia Nervosa and in Obesity Ann. N.Y. Acad. Sci., December 1, 2000; 921(1): 443 - 455. [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				S. Suzuki, I. Yamamoto, and J. Arita Mitogen-Activated Protein Kinase-Dependent Stimulation of Proliferation of Rat Lactotrophs in Culture by 3',5'-Cyclic Adenosine Monophosphate Endocrinology, June 1, 1999; 140(6): 2850 - 2858. [Abstract] [Full Text]

				T. Sweeney, G. Kelly, and D. O'Callaghan Seasonal Variation in Long-Day Stimulation of Prolactin Secretion in Ewes Biol Reprod, January 1, 1999; 60(1): 128 - 133. [Abstract] [Full Text]

				J. F. HYDE, J. P. MOORE JR., and A. CAI Galanin in Normal and Hyperplastic Anterior Pituitary Cells: From Pituitary Tumor Cell Lines to Transgenic Mice Ann. N.Y. Acad. Sci., December 21, 1998; 863(1): 48 - 55. [Abstract] [Full Text] [PDF]

				H. Oka, L. Jin, J. C. Reubi, X. Qian, B. W. Scheithauer, K. Fujii, T. Kameya, and R. V. Lloyd Pituitary Adenylate-Cyclase-Activating Polypeptide (PACAP) Binding Sites and PACAP/Vasoactive Intestinal Polypeptide Receptor Expression in Human Pituitary Adenomas Am. J. Pathol., December 1, 1998; 153(6): 1787 - 1796. [Abstract] [Full Text] [PDF]